Results 81 to 90 of about 563,198 (309)
ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya +9 more
wiley +1 more source
Clinical Medicine Insights: Case Reports, 2010 Vagal maneuvers cause increase in vagal tone, which has been shown to slow many types supraventricular tachycardia, such as atrial fibrillation (AF). However, the conversion of AF to sinus rhythm is usually not associated with vagal manuvers. Thus, AF is
Cheng-Huai Ruan
doaj +1 more source
Рациональная фармакотерапия в кардиологии, 2015 Aim. To study the changes of plasma levels of NT-proBNP and NT-proANP in patients with persistent atrial fibrillation (AF) treated with various antiarrhythmic drugs.Material and methods.
V. I. Podzolkov +2 more
doaj +1 more source
RNAseq shows an all-pervasive day-night rhythm in the transcriptome of the pacemaker of the heart
Scientific Reports, 2021 Physiological systems vary in a day-night manner anticipating increased demand at a particular time. Heart is no exception. Cardiac output is primarily determined by heart rate and unsurprisingly this varies in a day-night manner and is higher during the
Yanwen Wang +5 more
doaj +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 888-899, April 2025.Abstract Aims Heart failure with preserved ejection fraction (HFpEF) continues to be an increasingly common health problem associated with a high mortality rate. Elevated levels of Growth differentiation factor‐15 (GDF15) and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) are reportedly associated with poor clinical outcomes in a broad range of ...
Yoichiro Otaki +11 more
wiley +1 more source
ESC Heart FailureAims Differences in guideline‐directed medical therapy (GDMT) and clinical outcomes have been observed between heart failure (HF) patients with atrial fibrillation (AF) versus those in sinus rhythm.
Arietje J.L. Zandijk +6 more
doaj +1 more source
STATE OF THE ART PHARMACOLOGICAL THERAPY FOR ATRIAL FIBRILLATION
Российский кардиологический журнал, 2017 Pharmacological therapy remains the primary approach to atrial fibrillation (AF). Management of all AF patients includes the decision on rate or rhythm control. The latter means antiarrhythmic drugs application that are being selected primarily by safety
S. G. Kanorsky, Yu. S. Kovalenko
doaj +1 more source
Automatic Mode Switching in Atrial Fibrillation [PDF]
, 2005 Automatic mode switching (AMS) algorithms were designed to prevent tracking of atrial tachyarrhythmias (ATA) or other rapidly occurring signals sensed by atrial channels, thereby reducing the adverse hemodynamic and symptomatic consequences of a rapid ...
Antonio De, Simone +2 more
core
Artificial intelligence for heart rate variability analyzing with arrhythmias [PDF]
, 2019 Introduction. Existing standards of Heart Rate Variability (HRV) technology limit its use to sinus rhythm. A small number of extrasystoles is allowed, if the device used has special procedures for the detection and replacement of ectopic complexes ...
Marchitto, N. +3 more
core +1 more source
Physiological Measurement, 2015 Atrial fibrillation (AF) is usually detected by inspection of the electrocardiogram waveform, a task made difficult when the signal is distorted by noise.
M. Carrara +7 more
semanticscholar +1 more source